Octapharma is a family-owned global biopharmaceutical/healthcare company headquartered in Lachen, Switzerland. It develops and manufactures plasma-derived and recombinant therapies (high-quality human proteins sourced from human plasma and human cell lines) for patients worldwide, with products available in many countries.
Focus Areas
Notable Investments
